Prenatal Phthalate Exposure and Childhood Growth and Blood Pressure: Evidence from the Spanish INMA-Sabadell Birth Cohort Study

Abstract

BackgroundHuman evidence on the effects of early life phthalate exposure on obesity and cardiovascular disease risks, reported by experimental studies, is limited to a few cross-sectional studies.ObjectivesWe evaluated the associations between prenatal phthalate exposure and childhood growth and blood pressure in a Spanish birth cohort study.MethodsWe assessed exposure using the average of two phthalate metabolite spot-urine concentrations collected from the mothers in the first and third pregnancy trimesters (creatinine-adjusted, n = 391). Study outcomes were the difference in age- and sex-specific z-scores for weight between birth and 6 months of age; and repeated age- and sex-specific z-scores for body mass index (BMI) at 1, 4, and 7 years; waist-to-height ratio at 4 and 7 years; and age- and height-specific z-scores for systolic and diastolic blood pressure at 4 and 7 years.ResultsThe sum of five high-molecular-weight phthalate metabolites (ΣHMWPm) was associated with lower weight z-score difference between birth and 6 months (β per doubling of exposure = –0.41; 95% CI: –0.75, –0.06) and BMI z-scores at later ages in boys (β = –0.28; 95% CI: –0.60, 0.03) and with higher weight z-score difference (β = 0.24; 95% CI: –0.16, 0.65) and BMI z-scores in girls (β = 0.30; 95% CI: –0.04, 0.64) (p for sex interaction = 0.01 and 0.05, respectively). The sum of three low-molecular-weight phthalates (ΣLMWPm) was not significantly associated with any of the growth outcomes. ΣHMWPm and ΣLMWPm were associated with lower systolic blood pressure z-scores in girls but not in boys.ConclusionsThis study suggests that prenatal phthalate exposure may be associated with postnatal growth and blood pressure in a sex-specific manner. Inconsistencies with previous cross-sectional findings highlight the necessity for evaluating phthalate health effects in prospective studies.CitationValvi D, Casas M, Romaguera D, Monfort N, Ventura R, Martinez D, Sunyer J, Vrijheid M. 2015. Prenatal phthalate exposure and childhood growth and blood pressure: evidence from the Spanish INMA-Sabadell birth cohort study. Environ Health Perspect 123:1022–1029; http://dx.doi.org/10.1289/ehp.1408887

Adipose Tissue as a Site of Toxin Accumulation

“…LMW metabolites, including MnBP, MEP, and MiBP, have been associated with childhood obesity (77) (145) (388) (59) (48). Conversely, HMW metabolites have been associated with lower weight gain and lower BMI z-scores in boys but higher BMI in girls (406). …”

Prenatal Phthalate Exposures and Body Mass Index Among 4- to 7-Year-old Children

“…9,10,27 In a small Dutch study utilizing infant cord blood measures of oxidative DEHP metabolites, high cord blood concentrations of one metabolite, MEOHP, were inversely associated with BMI among infant boys. 27 However, phthalate concentrations measured in cord blood are susceptible to contamination 6 and may arise from hospital-based exposures to DEHP at delivery.…”

“…Valvi et al 9 reported associations of maternal urinary summed di-(2-ethylhexyl) phthalate (∑DEHP) metabolites with higher body mass index (BMI) in girls but lower BMI in boys in a Spanish birth cohort. In the Mount Sinai Children’s Environmental Health and Disease Prevention Research Center (MSSM), Buckley et al 10 reported associations of maternal urinary ∑DEHP metabolite concentrations with lower percent fat mass in children with no differences in associations between girls and boys, though the study was underpowered to identify sex differences.…”

Metals exposure and risk of small-for-gestational age birth in a Canadian birth cohort: The MIREC study

“…As there is uncertainty about the critical trimester of exposure for fetal growth, various studies have averaged contaminant concentrations across pregnancy (e.g. Valvi et al, 2015;Mora et al, 2015). Blood metal concentrations were based on the average of the first and third trimester measures if both were available.…”